CN203662831U - Cavity expansion haemostat - Google Patents
Cavity expansion haemostat Download PDFInfo
- Publication number
- CN203662831U CN203662831U CN201320771237.0U CN201320771237U CN203662831U CN 203662831 U CN203662831 U CN 203662831U CN 201320771237 U CN201320771237 U CN 201320771237U CN 203662831 U CN203662831 U CN 203662831U
- Authority
- CN
- China
- Prior art keywords
- sponge
- hemostasis
- sleeve
- expander
- alginate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940072056 alginate Drugs 0.000 claims abstract description 15
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 15
- 229920000615 alginic acid Polymers 0.000 claims abstract description 15
- 239000011248 coating agent Substances 0.000 claims abstract description 4
- 238000000576 coating method Methods 0.000 claims abstract description 4
- 235000010410 calcium alginate Nutrition 0.000 claims description 5
- 229960002681 calcium alginate Drugs 0.000 claims description 5
- 239000000648 calcium alginate Substances 0.000 claims description 5
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 229920002101 Chitin Polymers 0.000 claims description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical class CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 2
- 230000023597 hemostasis Effects 0.000 abstract description 25
- 230000006835 compression Effects 0.000 abstract description 8
- 238000007906 compression Methods 0.000 abstract description 8
- 230000002439 hemostatic effect Effects 0.000 abstract description 5
- 235000009161 Espostoa lanata Nutrition 0.000 abstract description 4
- 240000001624 Espostoa lanata Species 0.000 abstract description 4
- 230000007547 defect Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 229920001661 Chitosan Polymers 0.000 abstract 1
- 102000034240 fibrous proteins Human genes 0.000 abstract 1
- 108091005899 fibrous proteins Proteins 0.000 abstract 1
- 239000004745 nonwoven fabric Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 230000000025 haemostatic effect Effects 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010060964 Arterial haemorrhage Diseases 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Abstract
The utility model belongs to the field of medical apparatuses and relates to a cavity expansion haemostat. An air bag or a sponge expansion body (1) is covered with a hemostasis sleeve (2) to form the cavity expansion haemostat. The hemostasis sleeve (2) is an alginate coating sleeve, an alginate film sleeve, an alginate non-woven fabric sleeve, a chitosan sleeve or a fibrous protein sleeve. According to the cavity expansion haemostat, the defects of poor hemostasis effects and proneness to secondary damage caused by the fact that prior cotton ball and expansion sponges only depend on compression hemostasis are overcome; the cavity expansion haemostat is simple in structure, low in cost, convenient to use, provided with triple hemostatic functions of compression hemostasis, chemical hemostasis and biological hemostasis and capable of preventing secondary damage.
Description
Affiliated technical field
This utility model relates to medical instruments field, is specially a kind of tract expanded tampon device.
Background technology
Postoperative or a variety of causes of body cavities often causes hemorrhage, need effectively stop blooding.Conventionally adopt that cotton balls, expansion sponge are sucked blood, imbibition, hemostasis, effectively protect wound.But because compressing dynamics is inadequate, not good to small arterial hemorrhage haemostatic effect, in the time extracting and wound adhesion friction cause pain, make patient's endurable, also easily cause the secondary damage of wound.
Summary of the invention
The purpose of this utility model is only to rely on oppressive force hemostasis to cause haemostatic effect not good in order to overcome existing cotton balls, expansion sponge, easily cause the defect of secondary damage, provide a kind of simple in structure, with low cost, easy to use, possess hemostasis by compression, chemistry hemostasis and the triple hemostatic functions of biological hemostasis simultaneously, can avoid the tract expanded tampon device of secondary damage.
The purpose of this utility model realizes by following technical proposals:
Tract expanded tampon device of the present utility model, it is characterized in that forming tract expanded tampon device by air bag or sponge expander (1) upper parcel hemostasia sleeve (2), described hemostasia sleeve (2) is alginate coating cover, alginate thin-film covering, alginate nonwoven cloth case, chitin kind cover or fibrin class cover.
In such scheme, described sponge expander (1) is solid sponge expander or hollow sponge expander, and air bag or sponge expander (1) are cylindrical, square column type or one large one small important actor shape.
In such scheme, described air bag or sponge expander (1) are with bracing wire (4), and described hemostasia sleeve (2) is with bracing wire (3).
In such scheme, described alginate are calcium alginate or Zinc alginate.
Use procedure of the present utility model is as follows:
Tract expanded tampon device of the present utility model is filled in to hemorrhage tract, inject the liquid such as air, water and make airbag inflation, or by absorbing water, blood or body fluid etc., sponge expander is expanded, make air bag or sponge expander fully clog tract, and the hemostasia sleeve that can make to be wrapped on air bag or sponge expander fully contacts with wound very soon, discharge Ca
2+, promote the formation of thrombokinase, reach quick-acting haemostatic powder, and have effect antibacterial and promotion wound healing.Meanwhile, after air bag or sponge expander expand, there is good hemostasis by compression effect.After hemostasis completes, first take out air bag or sponge expander by bracing wire, then use normal saline moistening hemostasia sleeve, then take out hemostasia sleeve by bracing wire, can effectively avoid the risk of wound secondary damage.
The utlity model has following advantage: can be used for stopping blooding after vaginal hemorrhage, rectum hemostatic, oral cavity hemostasis, epistaxis hemostasis, nasal cavity, nasal sinuses postoperation hemostatic, rapidly, moisturizing, promotes that wound heals early in hemostasis, adhesion wound surface, easy cleaning, and there is bacteriostasis, there is again the function of expansion hemostasis by compression simultaneously, make this utility model there is hemostasis by compression, chemistry hemostasis and the triple haemostatic effects of biological hemostasis and bacteriostasis simultaneously, processing ease, quick, alleviates patient's pain, can effectively prevent wound secondary damage.
Therefore, this utility model has overcome existing cotton balls, expansion sponge only relies on hemostasis by compression to cause haemostatic effect not good, easily cause the defect of secondary damage, the tract expanded tampon device providing is simple in structure, with low cost, easy to use, possess hemostasis by compression, chemistry hemostasis and the triple hemostatic functions of biological hemostasis simultaneously, can avoid secondary damage.
Accompanying drawing explanation
Schematic diagram when Fig. 1 is this utility model employing air bag.
Schematic diagram when Fig. 2 is this utility model employing sponge expander.
In accompanying drawing, the implication of each numeral is: 1: air bag or sponge expander; 2: hemostasia sleeve; 3: hemostasia sleeve bracing wire; 4: air bag or the bracing wire of sponge expander.
The specific embodiment
Be described in further detail this utility model below in conjunction with drawings and Examples, but this utility model is not limited only to described embodiment.
Embodiment mono-
The tract expanded tampon device that this is routine, as shown in Figure 1, forms tract expanded tampon device by wrapping up hemostasia sleeve 2 on cylindrical air bag 1, and described hemostasia sleeve 2 is calcium alginate thin-film covering or Zinc alginate thin-film covering.On air bag 1, with bracing wire 4, hemostasia sleeve 2 is with bracing wire 3.
Embodiment bis-
The tract expanded tampon device that this is routine, except hemostasia sleeve 2 is calcium alginate nonwoven cloth case or Zinc alginate nonwoven cloth case, all the other are with embodiment mono-.
Embodiment tri-
The tract expanded tampon device that this is routine, except air bag 1 is one large one small round platform cylindricality, all the other are with embodiment bis-.
Embodiment tetra-
The tract expanded tampon device that this is routine, forms tract expanded tampon device by wrapping up hemostasia sleeve 2 on cylindrical, massive sponge expander 1, and hemostasia sleeve 2 is calcium alginate coating cover, and hemostasia sleeve 2 is not with bracing wire, and on sponge expander 1, with bracing wire 4, all the other are with embodiment mono-.
Embodiment five
The tract expanded tampon device that this is routine, as shown in Figure 2, forms tract expanded tampon device by wrapping up hemostasia sleeve 2 on the solid sponge expander 1 of square column type, and on sponge expander 1, with bracing wire 4, all the other are with embodiment bis-.
Embodiment six
The tract expanded tampon device that this is routine, forms tract expanded tampon device by wrapping up hemostasia sleeve 2 on the solid sponge expander 1 of one large one small round platform cylindricality, and on sponge expander 1, with bracing wire 4, all the other are with embodiment bis-.
Embodiment seven
The tract expanded tampon device that this is routine, forms tract expanded tampon device by wrapping up hemostasia sleeve 2 on cylinder type hollow sponge expander 1, and on sponge expander 1, with bracing wire 4, all the other are with embodiment bis-.
Embodiment eight
The tract expanded tampon device that this is routine, forms tract expanded tampon device by wrapping up hemostasia sleeve 2 on the hollow sponge expander 1 of one large one small round platform cylindricality, and on sponge expander 1, with bracing wire 4, all the other are with embodiment bis-.
Claims (4)
1. a tract expanded tampon device, it is characterized in that forming tract expanded tampon device by air bag or sponge expander (1) upper parcel hemostasia sleeve (2), described hemostasia sleeve (2) is alginate coating cover, alginate thin-film covering, alginate nonwoven cloth case, chitin kind cover or fibrin class cover.
2. tract expanded tampon device according to claim 1, is characterized in that described sponge expander (1) is solid sponge expander or hollow sponge expander, and air bag or sponge expander (1) are cylindrical, square column type or one large one small important actor shape.
3. tract expanded tampon device according to claim 1, is characterized in that described air bag or sponge expander (1) are with bracing wire (4), and described hemostasia sleeve (2) is with bracing wire (3).
4. tract expanded tampon device according to claim 1, is characterized in that described alginate are calcium alginate or Zinc alginate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320771237.0U CN203662831U (en) | 2013-12-01 | 2013-12-01 | Cavity expansion haemostat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320771237.0U CN203662831U (en) | 2013-12-01 | 2013-12-01 | Cavity expansion haemostat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203662831U true CN203662831U (en) | 2014-06-25 |
Family
ID=50959172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201320771237.0U Expired - Lifetime CN203662831U (en) | 2013-12-01 | 2013-12-01 | Cavity expansion haemostat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203662831U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111282141A (en) * | 2020-03-05 | 2020-06-16 | 安徽健邦宏扬医疗科技有限公司 | Disposable injection type cervical dilator |
-
2013
- 2013-12-01 CN CN201320771237.0U patent/CN203662831U/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111282141A (en) * | 2020-03-05 | 2020-06-16 | 安徽健邦宏扬医疗科技有限公司 | Disposable injection type cervical dilator |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20170118198A (en) | Hemostatic Compositions and Hemostasis Devices (Mutants) | |
| US20150342900A1 (en) | Device for Delivery of Skin Care Composition | |
| CN102850598B (en) | Alginate-gelatin-carboxymethylcellulose sodium blend membrane, and preparation and application thereof | |
| CN205433799U (en) | First aid is with device that stanchs fast | |
| CN201350088Y (en) | Hemostatic bar for inferior meatus | |
| CN204352025U (en) | The complete coated tapon of non-woven fabrics | |
| CN203662831U (en) | Cavity expansion haemostat | |
| CN204016935U (en) | A kind of medical bio magnetic dressing pastes | |
| CN101574275A (en) | Nosal hemostat | |
| CN203662832U (en) | Nasal cavity haemostat | |
| CN101890180A (en) | Wound dressing | |
| CN209154217U (en) | A kind of new medical hydrogel combine dressing | |
| CN201814902U (en) | Puff-ball woundplast | |
| CN202960940U (en) | Surgical anti-adhesive absorbent gauze | |
| CN204147173U (en) | The compound dressing of a kind of activated carbon fiber | |
| CN204246326U (en) | A kind of Wound dressing pastes | |
| CN208864639U (en) | A kind of high expansion liquid absorption sponge dressing | |
| CN203042642U (en) | Water-soluble chitosan woundplast | |
| CN201631278U (en) | Physical hemostat | |
| CN205849503U (en) | A kind of nosal hemostat | |
| CN205434083U (en) | Wound hemostasis device with function of adding medicine to repeatedly | |
| CN202505417U (en) | Hemostasis nose tampon | |
| CN204723261U (en) | Multi-functional wound dressing | |
| CN203885716U (en) | Self-adhesive alginate applying patch | |
| CN104001220B (en) | A kind of skin regeneration material and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20140625 |
|
| CX01 | Expiry of patent term |